# Zhou Zhou

> Zhou Zhou is a Series C investor at Dingxin Capital backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Dingxin Capital](https://shizune.co/investors/profile/dingxin-capital)
- Total investments: 1
- Last investment: Apr 2025
- Lead investor: 100%
- Last updated: Aug 2026

Zhou Zhou is a Series C investor at Dingxin Capital focused on Medical and Biotechnology. Zhou Zhou

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Novlead Biotech | Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations. |  | Series C | Apr 15, 2025 |  |

1 of 1 investments shown.

## Co-investors
- [EFung Capital](https://shizune.co/investors/profile/efung-capital) — VC Fund, 1 deal together
- [Guojin Group](https://shizune.co/investors/profile/guojin-group) — VC Fund, 1 deal together
- [Hunan Xingxiang Investment](https://shizune.co/investors/profile/hunan-xingxiang-investment) — VC Fund, 1 deal together
- [TriWise Capital](https://shizune.co/investors/profile/triwise-capital) — VC Fund, 1 deal together
- [Zhongshan Financial Investment Holdings](https://shizune.co/investors/profile/zhongshan-financial-investment-holdings) — VC Fund, 1 deal together

## About Dingxin Capital

VC Fund · Shenzhen, China

Dingxin Capital is an investment management agency that specializes in equity investments. The partners are mainly from domestic first-line investment institutions such as CDH, Jiuding and Zhongjin. They have deep accumulation and rich experience in the equity investment field, paying attention to the construction of the whole organization andtrying to build a truly sustainable competition. Investment institutions.

4 contacts available at Dingxin Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Deng Ning | Partner | https://shizune.co/investors/profile/deng-ning-5672 |
| Hu Hui | Founding partner | https://shizune.co/investors/profile/hu-hui-c320 |
| Yu Kang | Senior Investment Manager | https://shizune.co/investors/profile/yu-kang |
| Zhou Zhou | Senior Partner | https://shizune.co/investors/profile/zhou-zhou-522c |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Zhou Zhou invest in?

Zhou Zhou invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhou Zhou last invest?

The most recent investment recorded for Zhou Zhou closed in Apr 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co